Study to evaluate the effect of efavirenz coadministration on the pharmacokinetics of the active moieties of a combined oral contraceptive containing ethinyl estradiol and norgestimate [ethinylestradiol/norgestimate] in healthy female subjects.

Trial Profile

Study to evaluate the effect of efavirenz coadministration on the pharmacokinetics of the active moieties of a combined oral contraceptive containing ethinyl estradiol and norgestimate [ethinylestradiol/norgestimate] in healthy female subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2011

At a glance

  • Drugs Efavirenz; Ethinylestradiol/norgestimate
  • Indications HIV infections; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 02 Nov 2007 Status changed from in progress to completed.
    • 15 Jun 2007 Status changed from recruiting to in progress.
    • 24 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top